Insiders Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 16:31:31 11/12/2025 GMT			5-day change	1st Jan Change
317.90 ^CHF	-1.27%		+2.52%	+24.42%

03:50pm	Enliven Therapeutics, Inc. Announces Chief Executive Officer Changes, Effective December 11, 2025	CI
11:24am	ROCHE HOLDINGS AG : Goldman Sachs reiterates its Sell rating	ZD

Insiders

Enliven Therapeutics, Inc. Announces Chief Executive Officer Changes, Effective December 11, 2025	03:50pm	CI
Nokia Recruits Roche Executive as Chief People Officer	11-10	MT
Taysha Gene Therapies, Inc. Appoints David McNinch as Chief Commercial Officer in September 2025	11-04	CI
BASF Announces Departure of Dr. Nina Schwab-Hautzinger as Head of Corporate Communications & Government Relations, Effective January 31, 2026	10-23	CI
Roche Announces Appointment of Nina Schwab-Hautzinger as Head of Group Communications and Member of the Enlarged Corporate Executive Committee, Effective 1 February 2026	10-23	CI
Plus Therapeutics, Inc. Promotes Russ Havranek to Executive Vice President, Commercial and Corporate Strategy	10-21	CI
Claudia Süssmuth Dyckerhoff Decides Not to Stand for Re-Election as a Member of the Roche Board of Directors	10-03	CI
GSK commercial chief to become CEO at start of "pivotal" 2026	09-29	AN
Molecular Partners AG Announces Appointment of Martin Steegmaier, Ph.D. as Chief Scientific Officer and Member of Executive Committee, Effective October 1, 2025	08-21	CI
WEF clears founder Schwab of wrongdoing; appoints interim co-chairs	08-15	RE
WEF clears founder Schwab of wrongdoing; appoints interim co-chairs	08-15	RE
World Economic Forum names BlackRock's Larry Fink, Roche's André Hoffmann as interim co-chairs	08-15	RE
OraSure Technologies received takeover bid from industry entrepreneur, sources say	07-14	RE
Immuneonco Biopharmaceuticals Inc. Appoints Dr. Wu Zhuli as A Chief Medical Officer as Chief Medical Officer, Effect from June 9, 2025	06-09	CI
Arcellx, Inc. Announces Board Changes	03-20	CI
Roche Announces Management Changes	03-20	CI
Solvonis Therapeutics plc Appoints Dr. Renata Crome as Independent Non-Executive Director	03-11	CI
Claudia Böckstiegel and Nathalie Rachou Does Not Stand for Re-Election UBS Group Ag as Board Member	03-04	CI
Roche Announces Executive and Committee Changes	01-29	CI
BioXcel Therapeutics, Inc. Appoints Rajiv Patni to the Board	01-16	CI
Race Oncology Limited Announces the Appointment of Dr Megan Baldwin, to Its Board as an Independent Non-Executive Director, Effective 1 January 2025	12-17	CI
C4 Therapeutics, Inc. Appoints Steve Hoerter as Board of Directors	11-20	CI
Maeve Waldron-Lynch to Join Tango Therapeutics, Inc. as Senior Vice President, Head of Clinical Development	11-06	CI
Roche CEO 'Very Confident' on Outlook, Momentum	23/10/24	MT
Cogstate Appoints Kaycee Sink as Chief Medical Officer	14/10/24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : Markets need more proof of potential; guidance upgrade apparently won't cut it

October 23, 2025 at 04:05 pm

Roche will invest $50bn in US over five years.

April 22, 2025 at 09:49 am

Roche CEO 'Very Confident' on Outlook, Momentum

October 23, 2024 at 09:07 am